GenTarget, Inc., the renowned US biotech company, has announced the availability of new and enhanced lentivirus production services to its suite of lentivirus solutions. The firm specializes in advanced lentiviral technology, with a long history of providing researchers with proprietary bioagents and services for use in their research. As part of its ongoing commitment to growth, expansion and advancement of research, the company has announced that it has added new and enhanced services.